Fulgent Genetics, Inc. Net Income Loss

• Fulgent Genetics, Inc. showed a decrease of -41.7% in Net Income Loss from 2024 to 2025.
• This data is from Fulgent Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
• XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 12 years of available data (2014 to 2025), Fulgent Genetics, Inc.'s Net Income Loss has declined by 1,312.9%.
• Historical annual values: Fiscal year 2025: -$60.51 million | Fiscal year 2024: -$42.71 million | Fiscal year 2023: -$167.83 million | Fiscal year 2022: $143.40 million | Fiscal year 2021: $507.36 million | Fiscal year 2020: $214.31 million | Fiscal year 2019: -$411.0 thousand | Fiscal year 2018: -$5.61 million | Fiscal year 2017: -$2.51 million | Fiscal year 2016: -$5.35 million | Fiscal year 2015: -$8.31 million | Fiscal year 2014: -$4.28 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026